Drawing from more than 20 years of experience in the Canadian pharmaceutical and specialty biopharmaceutical markets, Joe Farago has honed his skills through diverse roles, including market access, sales, marketing, government affairs, supply chain and operations.

He joined Innovative Medicines Canada in 2016 as executive director of market access, responsible for leading the pharmaceutical industry's market access policy, including strategies for the private payer market, engagement with the pan-Canadian Pharmaceutical Alliance and driving national innovation initiatives.

Farago is committed to advancing a proactive, research-based approach to address current policy challenges and serves as an advocate for Canada's dual private and public health-care coverage. His work encourages timely access to innovative medicines for employees and their families, contributing to the total health of Canadians, the broader healthcare system and the economy.

Prior to joining IMC, he played a key role in establishing CSL Ltd. as a market leader in the plasma protein specialty market in Canada. Farago is a Carleton University graduate, holding a BSc. He resides in Ottawa with his wife, three children and grandson.